From: Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial
Variable
OR
95% CI
p value
Randomization to levosimendan
0.38
0.15–0.94
0.037
Age
0.98
0.94–1.02
0.282
RACHS
–
0.001